News

Drs. Stravitz and Sanyal being interviewed in front of film crew

Featured Stories

EASL News

Director Sanyal announces promising Phase 2 trial results on survodutide

Fri, Jun 7, '24

Transplant graphic

EASL News

Dr. Bajaj reports success of fecal microbiota transplants in cirrhosis patients

Thu, Jun 6, '24

Newsletter icon

NEWSLETTER

June 2024 Newsletter

Thu, Jun 6, '24

Headshot for Dr Bajaj

Publication News

Special issue of the American Journal of Gastroenterology on obesity features op-ed by co-editor Dr. Jasmohan Bajaj

Wed, Jun 5, '24

Headshot for Richard Sterling

BLOG

Dr. Sterling reviews the new AASLD practice guidelines on using blood-based and imaging tests

Tue, May 21, '24

Newsletter icon

NEWSLETTER

May 2024 Newsletter

Mon, Apr 29, '24

Cooking meatless

VCU NEWS

Liver patients see benefits after going meatless for one meal

Thu, May 2, '24

MCV FOUNDATION

Redefining metabolic health

Thu, May 2, '24

Newsletter icon

NEWSLETTER

April 2024 Newsletter

Mon, Apr 29, '24

Video teaser

PRESENTATION

Dr. Siddiqui discusses MASH patients post-transplant

Mon, Apr 29, '24

SSLI and GEO staff

VCU HEALTH

To fight liver disease worldwide, ‘MASH School’ at VCU welcomes Brazilian specialists

Mon, Apr 8, '24

Top Docs graphic

VCU HEALTH

Four Institute Faculty among Richmond Top Docs

Tue, Apr 2, '24

Headshot for Dr Lauridsen

BLOG

Labs and Leadership

Wed, Mar 27, '24

Headshot for Dr Bajaj

Faculty Honor

Congratulations to Jasmohan Bajaj, M.D., on his election to the American Association of Physicians. Only seven other VCU physicians hold this honor.

Thu, Mar 21, '24

Image of Resmetirom

NEWS

Director’s statement on the first drug approved to treat MASH

Thu, Mar 14, '24

Newsletter icon

Newsletter

March 2024 Newsletter

Thu, Mar 14, '24

Headshot for Dr Karpen

NEWS

The Institute welcomes Dr. Saul Karpen as CSO

Mon, Mar 4, '24

Image of weight loss pills in a lab

Featured

Survodutide, a Glucagon/GLP-1 RA, Reduces MASH in Phase 2 Trial

Tue, Feb 27, '24

Micrograph of cells

Featured

Liver disease MASH is next target for obesity drugs in development

Tue, Feb 27, '24

Jerry Colca of Cirius Therapeutics visits the liver institute

Video

Jerry Colca of Cirius Therapeutics visits the liver institute

Tue, Feb 20, '24

A doctor holds a liver

VCU Health

1 of 10 veterans diagnosed with dementia may instead have cognitive decline from cirrhosis

Wed, Jan 31, '24

Student stands on Monroe Park Campus

VCU News

A student’s interest in liver disease is fueled by his own experience

Wed, Jan 31, '24

Dr Bajaj in his lab

Podcast

ACG Clinical Guideline: Alcohol-Associated Liver Disease

Tue, Jan 16, '24

Infographic about MASH

RESEARCH

A milestone in identifying patients at-risk for fatty liver disease

Fri, Jan 12, '24

Media Inquiries

For media inquiries related to the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, please contact:

A.J. Hostetler
Communications Director
VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health
aj.hostetler@vcuhealth.org
804-828-9652